The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.

Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.

DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.

J&J said its Ottava robotic platform has six robotic arms, “zero footprint,” and can be used for various procedures.